新光药业
(300519)
| 流通市值：13.84亿 | | | 总市值：19.41亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 595,843,819.92 | 543,945,792.9 | 604,265,223.53 | 546,071,619.02 |
| 应收票据及应收账款 | 7,753,496.42 | 9,988,937.91 | 16,467,773.43 | 11,985,479.89 |
| 应收账款 | 7,753,496.42 | 9,988,937.91 | 16,467,773.43 | 11,985,479.89 |
| 应收款项融资 | 1,046,966.56 | 748,356.48 | 1,296,481 | 606,739.3 |
| 预付款项 | 3,585,065.88 | 2,426,448.68 | 3,720,895.03 | 2,345,359.82 |
| 其他应收款合计 | 130,277.23 | 180,188.25 | 191,348.57 | 223,101.88 |
| 存货 | 50,335,058.98 | 71,418,704.23 | 59,957,414.26 | 53,431,644.62 |
| 其他流动资产 | 1,158,132.76 | 1,459,871.55 | 1,644,323.77 | 1,141,259.58 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 799,852,817.75 | 785,168,300 | 777,543,459.59 | 755,805,204.11 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 20,916,513.31 | 21,395,621.76 | 20,877,930.64 | 20,765,861.7 |
| 投资性房地产 | - | - | 22,938.92 | 23,055.92 |
| 固定资产 | 115,492,535.75 | 104,472,731.6 | 106,846,880.29 | 108,332,885.87 |
| 在建工程 | 103,365.11 | 10,999,084.05 | 4,689,823.01 | 1,483,207.96 |
| 无形资产 | 8,093,764.01 | 8,166,770.8 | 8,434,951.88 | 8,717,643.43 |
| 递延所得税资产 | 258,597.9 | 203,282.15 | 853,095.11 | 805,673.49 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 144,864,776.08 | 145,237,490.36 | 141,725,619.85 | 140,128,328.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 944,717,593.83 | 930,405,790.36 | 919,269,079.44 | 895,933,532.48 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 60,815,965.99 | 63,875,802.19 | 59,905,711.53 | 57,153,728.9 |
| 应付账款 | 60,815,965.99 | 63,875,802.19 | 59,905,711.53 | 57,153,728.9 |
| 合同负债 | 2,724,809.9 | 157,191.87 | 242,088.05 | 3,354,155.91 |
| 应付职工薪酬 | 595,332.09 | 4,026,317.31 | 684,726.42 | 618,291.41 |
| 应交税费 | 3,990,264.54 | 4,765,567.07 | 9,568,268.05 | 5,263,422.71 |
| 其他应付款合计 | 814,662.85 | 4,234,883.79 | 779,554.27 | 1,348,045.73 |
| 其他流动负债 | 354,225.29 | 20,434.94 | 31,471.45 | 436,040.27 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 69,295,260.66 | 77,080,197.17 | 71,211,819.77 | 68,173,684.93 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 6,516,079.34 | 6,842,438.54 | 7,168,797.71 | 7,143,556.91 |
| 递延所得税负债 | - | - | 502,056.03 | 485,245.68 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,878,465.8 | 9,204,825 | 10,033,240.2 | 9,991,189.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 78,173,726.46 | 86,285,022.17 | 81,245,059.97 | 78,164,873.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 2,877,779.38 | 3,285,021.56 | 2,844,984.11 | 2,749,725.52 |
| 盈余公积 | 111,923,292.31 | 111,923,292.31 | 105,498,507.33 | 105,498,507.33 |
| 未分配利润 | 430,453,761.16 | 407,623,419.8 | 408,391,493.51 | 388,231,391.13 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 866,543,867.37 | 844,120,768.19 | 838,024,019.47 | 817,768,658.5 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 866,543,867.37 | 844,120,768.19 | 838,024,019.47 | 817,768,658.5 |
| 负债和股东权益合计 | 944,717,593.83 | 930,405,790.36 | 919,269,079.44 | 895,933,532.48 |
| 公告日期 | 2024-04-26 | 2024-04-22 | 2023-10-25 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |